Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 10Phase 1/2 6Phase 3 4Phase NA 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Renal Cell 4Sarcoma 2Refractory Solid Tumors 2Neoplasms 2Kidney Neoplasms 1

Interventions

Ifosfamide 8Doxorubicin 8Blood Specimen Collection 8Radiosurgery 7Proton Therapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Standard of Care 4Radiotherapy 4Magnetic Resonance Spectroscopy 4X-Rays 3Vincristine 3Radiation Dose Hypofractionation 3Palliative Care 3Methods 3Mesna 3pegfilgrastim 2pazopanib 2dexamethasone acetate 2Trastuzumab 2Transurethral Resection of Bladder 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Protons 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Methotrexate 2Melphalan 2Heavy Ion Radiotherapy 2Gene Expression Profiling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Sarcoma × pazopanib × Clear all
NCT04199026 2026-02-19

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

M.D. Anderson Cancer Center

Phase NA Recruiting
20 enrolled
Sarcoma

Sarcoma

NCT01446809 2020-04-13

Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma

University of Washington

Phase NA Completed
23 enrolled 16 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡